Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Study of Phenylketonuria (PKU)

NCT04452513 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT04452513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Study of Phenylketonuria (PKU)
Lead sponsor
BioMarin Pharmaceutical
Phase
Observational
Overall status
Completed
Start date
October 11, 2019
Completion date
June 2, 2022
Enrollment
32 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonurias